Epcoritamab for Relapsed/Refractory EBV+ Post‐Transplant Lymphoproliferative Disorder of DLBCL‐Type

Abstract Background Patients with relapsed/refractory post‐transplant lymphoproliferative disorder (R/R PTLD) following solid‐organ transplants (SOT) or hematopoietic stem cell transplants (HSCT) after frontline chemoimmunotherapy have dismal outcomes. There is no standard of care for this group of...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Li Yuan Chan, Simon O'Connor, Dima El‐Sharkawi, Sunil Iyengar
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Wiley 2025-12-01
Cyfres:	eJHaem
Pynciau:	bispecific antibodies diffuse large b‐cell lymphoma EBV post‐transplant lymphoproliferative disorders
Mynediad Ar-lein:	https://doi.org/10.1002/jha2.70156
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!